|
SENP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64701585703142E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19819709709645E-11 |
| Normal-vs-Stage2 |
1.17330000048987E-07 |
| Normal-vs-Stage3 |
1.76059167245057E-12 |
| Normal-vs-Stage4 |
5.39050026837629E-10 |
| Stage1-vs-Stage2 |
5.915800E-01 |
| Stage1-vs-Stage3 |
5.492200E-02 |
| Stage1-vs-Stage4 |
1.748440E-01 |
| Stage2-vs-Stage3 |
4.295200E-01 |
| Stage2-vs-Stage4 |
5.315800E-01 |
| Stage3-vs-Stage4 |
9.102400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.60902410786912E-14 |
| Normal-vs-AfricanAmerican |
9.404500E-04 |
| Normal-vs-Asian |
2.47370000039382E-07 |
| Caucasian-vs-AfricanAmerican |
1.631580E-01 |
| Caucasian-vs-Asian |
3.742200E-01 |
| AfricanAmerican-vs-Asian |
5.004800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.96690449985704E-11 |
| Normal-vs-Female |
1.80100379054693E-12 |
| Male-vs-Female |
8.626200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.79290043817093E-10 |
| Normal-vs-Age(41-60Yrs) |
4.20397050504562E-12 |
| Normal-vs-Age(61-80Yrs) |
8.57292015155053E-12 |
| Normal-vs-Age(81-100Yrs) |
8.801600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.918380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.155500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.373000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.422800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.388000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.079600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.357100E-03 |
| Classical-VS-Follicular |
1.797850E-01 |
| Classical-VS-Other |
7.612400E-01 |
| Classical-VS-Normal |
1.78329573330416E-11 |
| Tall-VS-Follicular |
4.652200E-02 |
| Tall-VS-Other |
1.695800E-01 |
| Tall-VS-Normal |
1.06750164263758E-11 |
| Follicular-VS-Other |
8.612800E-01 |
| Follicular-VS-Normal |
6.83769996179251E-09 |
| Other-VS-Normal |
9.701100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.42807987657534E-12 |
| Normal-vs-N1 |
1.21100000027852E-08 |
| N0-vs-N1 |
8.650000E-01 |
|
|
